EURAZEO (EPA:RF) | Finanzwire

Basculer en Français

10052	Companies
205147	Keywords
135406	Articles
108777	Press releases

Home
Companies
EURAZEO

REGULATED PRESS RELEASE

published on 02/17/2025 at 17:35, 1 year 1 month ago

Disclosure of transactions in own shares from February 10 to February 14, 2025
BRIEF

published on 02/12/2025 at 08:05, 1 year 1 month ago

EURAZEO Leads €29 Million Series B for Germitec

EURAZEO Healthcare Investment FDA Certification Germitec Disinfection Solutions
REGULATED PRESS RELEASE

published on 02/12/2025 at 08:00, 1 year 1 month ago

EURAZEO PARTICIPATES IN GERMITEC’S EUR 29 MILLION SERIES B FUNDRAISING
Eurazeo participates in Germitec’s €29 million Series B fundraising to support the development of innovative High-Level Disinfection solutions for ultrasound probes. Nov Santé Actions Non Cotées is the lead investor

EURAZEO Germitec Series B Fundraising High-Level Disinfection Ultrasound Probes
BRIEF

published on 02/11/2025 at 17:40, 1 year 1 month ago

EURAZEO Reports Share and Voting Rights Numbers as of January 31, 2025

Voting Rights EURAZEO AMF Regulations Capital Disclosure January 2025
REGULATED PRESS RELEASE

published on 02/11/2025 at 17:35, 1 year 1 month ago

Disclosure of the number of shares and the total number of voting rights as of January 31, 2025
Eurazeo discloses total shares and voting rights. Leading European investment group with diverse assets of 35.5 billion euros, focusing on private equity, private debt, real estate, and infrastructure

Voting Rights Shares EURAZEO Investment Group European
REGULATED PRESS RELEASE

published on 02/10/2025 at 17:35, 1 year 1 month ago

Disclosure of transactions in own shares from February 3 to February 7, 2025
REGULATED PRESS RELEASE

published on 02/03/2025 at 17:35, 1 year 1 month ago

Disclosure of transactions in own shares from January 27 to January 31, 2025
REGULATED PRESS RELEASE

published on 01/27/2025 at 17:35, 1 year 1 month ago

Disclosure of transactions in own shares from January 20 to January 24, 2025
REGULATED PRESS RELEASE

published on 01/20/2025 at 17:35, 1 year 1 month ago

Disclosure of transactions in own shares from January 13 to January 17, 2025
REGULATED PRESS RELEASE

published on 01/13/2025 at 17:35, 1 year 2 months ago

Disclosure of transactions in own shares from January 6 to January 10, 2025

Accesswire

Published on 03/19/2026 at 07:30, 35 minutes ago

Tocvan Drone Magnetic Data Strengthens Gold-Silver Targets Across Gran Pilar; Identifies Broad Zones for Expansion Potential
Published on 03/19/2026 at 06:35, 1 hour 30 minutes ago

Golden Lake Announces Securityholder Approval of Arrangement with McEwen Inc.
Published on 03/19/2026 at 01:05, 7 hours ago

Prospect Ridge Announces Closing of Flow-Through Share Private Placement
Published on 03/18/2026 at 23:45, 8 hours 20 minutes ago

Orogen Royalties Announces Private Placement Update
Published on 03/18/2026 at 21:00, 11 hours 5 minutes ago

PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie

View all ACCESSWIRE

EQS Group

Published on 03/19/2026 at 07:50, 15 minutes ago

AFYREN obtains ISO 9001 certification, a globally acknowledged standard of rigor and performance, for its AFYREN NEOXY plant
Published on 03/19/2026 at 07:35, 30 minutes ago

Lenzing advances its transformation: Higher EBITDA, stronger free cash flow and more than EUR 200 million in cost savings
Published on 03/19/2026 at 07:30, 35 minutes ago

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS
Published on 03/19/2026 at 07:30, 35 minutes ago

The Nordex Group receives orders totaling 54 MW from Prowind in Germany
Published on 03/19/2026 at 07:30, 35 minutes ago

Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation

Les Echos

Published on 03/19/2026 at 07:00, 1 hour 5 minutes ago

bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 1 hour 5 minutes ago

2025 Annual results and new strategic signature
Published on 03/18/2026 at 19:41, 12 hours 23 minutes ago

Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 14 hours 5 minutes ago

Deezer achieves profitability in FY25 as strategy delivers tangible results
Published on 03/18/2026 at 17:45, 14 hours 20 minutes ago

Infotel : 2025 full-year results. Launch of a new Infotel 2030 strategic plan. Revenue target of €500 million by 2030.

View all LES ECHOS COMFI WIRE